Sharekhan's research repor on Ashok Leyland
Ashok Leyland Ltd (ALL) is witnessing month on month improvement in MHCV sales as economic activities pick up with the Government opening the economy. We expect MHCV industry to witness stronger recovery cycle from FY22 driven by normalisation of economic activity and pent up demand. With the launch of a new LCV platform, ALL has closed an important gap in its product portfolio and is expecting to double its addressable market size. We expect strong 56% earnings CAGR over FY20-23 period driven by healthy volume growth and margin expansion due to operating leverage.
Outlook
We retain Buy rating on ALL with revised TP of Rs 98 as we rollover to FY23 earnings.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!